Skip to main content
Jean Yang, MD, Ophthalmology, Mineola, NY

JeanJinquiYangMD

Ophthalmology Mineola, NY

Cataract Related, Retinal Disease

Physician

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yang's full profile

Already have an account?

  • Office

    153 Jericho Tpke
    Unit B
    Mineola, NY 11501
    Phone+1 516-873-0200
    Fax+1 516-873-0243

Education & Training

  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Ophthalmology, 1993 - 1996
  • Drexel University College of Medicine/Hahnemann University
    Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 1992 - 1993
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • NY State Medical License
    NY State Medical License 1997 - 2026
  • MA State Medical License
    MA State Medical License 1996 - 2002
  • NJ State Medical License
    NJ State Medical License 1998 - 2001
  • PA State Medical License
    PA State Medical License 1992 - 1993
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Press Mentions

  • Cityblock, Tufts Health Plan Expand Collaboration in Massachusetts
    Cityblock, Tufts Health Plan Expand Collaboration in MassachusettsSeptember 16th, 2021
  • Third Generation Cephalosporins and piperacillin/tazobactam Have Distinct Impacts on the Microbiota of Critically Ill Patients
    Third Generation Cephalosporins and piperacillin/tazobactam Have Distinct Impacts on the Microbiota of Critically Ill PatientsMarch 31st, 2021

Professional Memberships